Cefuroxime
Active ingredient description
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Cefuroxime is the active ingredient of these drugs:
Hong Kong South Africa
Ecuador
Ireland
Austria Finland France Hong Kong Netherlands
South Africa
Hong Kong
Cyprus Estonia Hong Kong Lithuania Singapore
Ecuador
Singapore
South Africa
Ecuador
Poland
Poland
South Africa
Hong Kong
Poland
Ireland
Singapore
South Africa
South Africa
Ecuador
Cyprus Germany
Ecuador
Ecuador
Ecuador
Hong Kong
Ecuador
Hong Kong
Ecuador
Ecuador
Ecuador Poland South Africa
South Africa
Hong Kong
South Africa
Austria
Italy
Hong Kong
Estonia Germany
Hong Kong
Ecuador
Estonia Hong Kong Poland
Ecuador
France
Cyprus
Ecuador
Italy
Brazil
South Africa
Brazil
Italy
Ecuador
Spain
Lithuania
Lithuania
Hong Kong
Singapore
Poland
Poland
Italy
Tunisia
Austria Estonia Lithuania Netherlands Poland
Ecuador
Ecuador Estonia Hong Kong Lithuania Poland
Hong Kong
Ecuador Poland
Spain
South Africa
South Africa
Hong Kong
Brazil
Tunisia
Cyprus New Zealand
Brazil Cyprus Estonia Finland Hong Kong
Australia Austria Brazil Cyprus Ecuador
Tunisia
South Africa
Poland
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Unique ingredient identifier (UNII)
O1R9FJ93ED - CEFUROXIME
CAS registry number
55268-75-2 - cefuroxime
56238-63-2 - Cefuroxime sodium
64544-07-6 - Cefuroxime axetil
SNOMED-CT
372833007 - Cefuroxime (substance)